Drug Trial Radar · NCT04867317
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
Last checked: Nov 20, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
172
Planned (sponsor's estimate)
Start
Jan 13, 2025
Primary completion
Feb 28, 2027
Study completion Sep 30, 2029
Sponsor
- Lead sponsor
- VA Office of Research and DevelopmentFederal agency
- Sponsor type
- Federal agency
- First posted
- Apr 30, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 21 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether growth hormone replacement therapy (GHRT) is effective versus placebo in the improvement of Quality of Life in patients with adult growth hormone deficiency (AGHD) and mild traumatic brain injury (mTBI).
Conditions
- Adult Growth Hormone Deficiency
- Mild Traumatic Brain Injury
Interventions
SomatropinDrug
Participants (n=172) will be randomized in a 1:1 ratio to rhGH (n=86) versus placebo (n=86) for six months, stratified by participating site. Both study participants and the study team will be blinded to treatment assignment. All participants will complete in-clinic follow-ups at Days 14, 40, 65, and 90 (3 months) and at day 180 (6 months). The primary outcome will be the mean difference in QoL-AGHDA scores between treatment arms at 6 months follow-up. Patients will discontinue the study intervention at 6 months, and will be followed-up two weeks subsequent, in order to assure patient safety and wellness, and to ensure maximal facilitation of patient transition back into routine care.
PlaceboOther
Participants (n=172) will be randomized in a 1:1 ratio to rhGH (n=86) versus placebo (n=86) for six months, stratified by participating site. Both study participants and the study team will be blinded to treatment assignment. All participants will complete in-clinic follow-ups at Days 14, 40, 65, and 90 (3 months) and at day 180 (6 months). The primary outcome will be the mean difference in QoL-AGHDA scores between treatment arms at 6 months follow-up. Patients will discontinue the study intervention at 6 months, and will be followed-up two weeks subsequent, in order to assure patient safety and wellness, and to ensure maximal facilitation of patient transition back into routine care.
Primary outcomes
What the sponsor says the trial is designed to measure.
- QoL-AGHDA (Quality of Life-Assessment of Adult Growth Hormone in Adults)Time frame: 6 months
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Birmingham VA Medical Center, Birmingham, AL
Birmingham, Alabama · Not yet recruiting
Phoenix VA Health Care System, Phoenix, AZ
Phoenix, Arizona · Not yet recruiting
VA San Diego Healthcare System, San Diego, CA
San Diego, California · Not yet recruiting
Rocky Mountain Regional VA Medical Center, Aurora, CO
Aurora, Colorado · Recruiting
Washington DC VA Medical Center, Washington, DC
Washington D.C., District of Columbia · Not yet recruiting
Atlanta VA Medical and Rehab Center, Decatur, GA
Decatur, Georgia · Active not recruiting
VA Ann Arbor Healthcare System, Ann Arbor, MI
Ann Arbor, Michigan · Recruiting
Minneapolis VA Health Care System, Minneapolis, MN
Minneapolis, Minnesota · Recruiting
Kansas City VA Medical Center, Kansas City, MO
Kansas City, Missouri · Not yet recruiting
Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE
Omaha, Nebraska · Not yet recruiting
Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC
Salisbury, North Carolina · Not yet recruiting
Oklahoma City VA Medical Center, Oklahoma City, OK
Oklahoma City, Oklahoma · Not yet recruiting
VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX
Dallas, Texas · Not yet recruiting
Michael E. DeBakey VA Medical Center, Houston, TX
Houston, Texas · Recruiting
South Texas Health Care System, San Antonio, TX
San Antonio, Texas · Not yet recruiting
VA Puget Sound Health Care System Seattle Division, Seattle, WA
Seattle, Washington · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.